CENTESSA PHARMACEUTICALS PLC - AMERICAN DEPOSITARY
17.04
22-November-24 15:44:58
15 minutes delayed
Stocks
-1.15
-6.32%
Today's range
16.95 - 18.33
ISIN
N/A
Source
NASDAQ
-
Centessa Pharmaceuticals Announces New Chief People Officer Karen Anderson
30 Nov 2022 07:00:01 By Nasdaq GlobeNewswire
-
10 Nov 2022 06:00:04 By Nasdaq GlobeNewswire
-
03 Nov 2022 08:04:09 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
31 Oct 2022 07:00:02 By Nasdaq GlobeNewswire
-
14 Sep 2022 08:00:01 By Nasdaq GlobeNewswire
-
12 Sep 2022 06:00:00 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
29 Aug 2022 07:00:00 By Nasdaq GlobeNewswire
-
10 Aug 2022 05:30:00 By Nasdaq GlobeNewswire
-
25 Jul 2022 07:00:00 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors
01 Jul 2022 07:40:42 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
06 Jun 2022 07:00:02 By Nasdaq GlobeNewswire
-
05 Jun 2022 06:00:00 By Nasdaq GlobeNewswire
-
02 Jun 2022 05:29:00 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Updates
16 May 2022 06:00:01 By Nasdaq GlobeNewswire
-
30 Mar 2022 15:01:00 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals to Present at the Guggenheim Genomic Medicines & Rare Disease Day
23 Mar 2022 15:30:00 By Nasdaq GlobeNewswire
-
Centessa Pharmaceuticals Expands Management Team and Adds to Extensive Development Expertise
07 Mar 2022 06:30:00 By Nasdaq GlobeNewswire
-
24 Feb 2022 06:30:01 By Nasdaq GlobeNewswire
-
14 Dec 2021 06:30:00 By Nasdaq GlobeNewswire